BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 2497520)

  • 1. Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes.
    Cross SL; Halden NF; Lenardo MJ; Leonard WJ
    Science; 1989 Apr; 244(4903):466-9. PubMed ID: 2497520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes.
    Lowenthal JW; Ballard DW; Böhnlein E; Greene WC
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2331-5. PubMed ID: 2494663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins.
    John S; Reeves RB; Lin JX; Child R; Leiden JM; Thompson CB; Leonard WJ
    Mol Cell Biol; 1995 Mar; 15(3):1786-96. PubMed ID: 7862168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcriptionally active factors mediating the effect of the HTLV-I Tax transactivator on the IL-2R alpha kappa B enhancer include the product of the c-rel proto-oncogene.
    Crenon I; Béraud C; Simard P; Montagne J; Veschambre P; Jalinot P
    Oncogene; 1993 Apr; 8(4):867-75. PubMed ID: 8455941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The same target sequences are differentially important for activation of the interleukin 2 receptor alpha-chain gene in two distinct T-cell lines.
    Toledano MB; Roman DG; Halden NF; Lin BB; Leonard WJ
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1830-4. PubMed ID: 2308942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the IL-2 receptor alpha-gene. Interaction of a kappa B binding protein with cell-specific transcription factors.
    Freimuth WW; Depper JM; Nabel GJ
    J Immunol; 1989 Nov; 143(9):3064-8. PubMed ID: 2809216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning of R kappa B, a novel DNA-binding protein that recognizes the interleukin-2 receptor alpha chain kappa B site.
    Adams BS; Leung KY; Hanley EW; Nabel GJ
    New Biol; 1991 Nov; 3(11):1063-73. PubMed ID: 1777480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression.
    Hoyos B; Ballard DW; Böhnlein E; Siekevitz M; Greene WC
    Science; 1989 Apr; 244(4903):457-60. PubMed ID: 2497518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the interleukin-2 receptor alpha gene: regulatory role for DNA-protein interactions flanking the kappa B enhancer.
    Ballard DW; Böhnlein E; Hoffman JA; Bogerd HP; Dixon EP; Franza BR; Greene WC
    New Biol; 1989 Oct; 1(1):83-92. PubMed ID: 2518691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa B site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel.
    Tan TH; Huang GP; Sica A; Ghosh P; Young HA; Longo DL; Rice NR
    Mol Cell Biol; 1992 Sep; 12(9):4067-75. PubMed ID: 1508203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between NF-kappa B- and serum response factor-binding elements activates an interleukin-2 receptor alpha-chain enhancer specifically in T lymphocytes.
    Kuang AA; Novak KD; Kang SM; Bruhn K; Lenardo MJ
    Mol Cell Biol; 1993 Apr; 13(4):2536-45. PubMed ID: 8455627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1, HTLV-I and the interleukin-2 receptor: insights into transcriptional control.
    Böhnlein E; Lowenthal JW; Wano Y; Franza BR; Ballard DW; Greene WC
    Haematol Blood Transfus; 1989; 32():393-401. PubMed ID: 2625257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B.
    Stein B; Baldwin AS
    Mol Cell Biol; 1993 Nov; 13(11):7191-8. PubMed ID: 8413306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved high-affinity NF-kappa B binding site in the interferon regulatory factor-1 promoter is not occupied by NF-kappa B in vivo and is transcriptionally inactive.
    Rein T; Schreck R; Willenbrink W; Neubert WJ; Zorbas H; Bäuerle PA
    J Inflamm; 1995; 45(4):269-82. PubMed ID: 8867671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kappa B binding proteins are constitutively expressed in an IL-2 autocrine human T cell line.
    Hémar A; Cereghini S; Cornet V; Blank V; Israël A; Greene WC; Dautry-Varsat A
    J Immunol; 1991 Apr; 146(7):2409-16. PubMed ID: 2005404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
    Mondal D; Alam J; Prakash O
    J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG I(Y) interferes with the DNA binding of NF-AT factors and the induction of the interleukin 4 promoter in T cells.
    Klein-Hessling S; Schneider G; Heinfling A; Chuvpilo S; Serfling E
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15311-6. PubMed ID: 8986808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo regulation of interleukin-2 receptor alpha gene transcription by the coordinated binding of constitutive and inducible factors in human primary T cells.
    Algarté M; Lécine P; Costello R; Plet A; Olive D; Imbert J
    EMBO J; 1995 Oct; 14(20):5060-72. PubMed ID: 7588634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A second sequence element located 3' to the NF-kappa B-binding site regulates IL-2 receptor-alpha gene induction.
    Pomerantz JL; Mauxion F; Yoshida M; Greene WC; Sen R
    J Immunol; 1989 Dec; 143(12):4275-81. PubMed ID: 2687377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.
    Kawakami K; Scheidereit C; Roeder RG
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4700-4. PubMed ID: 3133660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.